Major Adverse Cardiovascular Events
📧 Sign up to get email alerts when something new happens for Major Adverse Cardiovascular Events.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-11-13Clinical Trial Update: Effect of Evolocumab on Chronic Total Occlusions (EVOLO-CTO) [Phase 4]
Phase 4 trial update examining evolocumab for in-stent restenosis and major adverse cardiovascular events.